← Open Payments lookup

JOSHUA OGLEHART: Open Payments

NPI 1811338999 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,554 in 108 payments from 15 companies in 2025. Trend: 2023 $1,309 · 2024 $3,524 · 2025 $2,554

Food & beverage: $2,453Education: $101
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.13$484
Neurocrine BioSciences, Inc.15$434
ABBVIE INC.21$412
Otsuka America Pharmaceutical, Inc.19$347
Janssen Pharmaceuticals, Inc14$261
Luye Pharma (USA) Ltd.9$200
Indivior Inc.1$125
E.R. Squibb & Sons, L.L.C.3$49
Vanda Pharmaceuticals Inc.2$43
Alkermes, Inc.2$43

Products named: INGREZZA, VRAYLAR, AUSTEDO XR, INVEGA SUSTENNA, ERZOFRI EXTENDED-RELEASE, ABILIFY ASIMTUFII, ABILIFY MAINTENA, SUBLOCADE.

Industry payments across OH — which companies pay providers there.